# Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

> **NCT01235260** · — · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.**

## Conditions studied

- Diabetes Mellitus
- Foot Ulcer
- Diabetic Foot
- Diabetic Neuropathies

## Interventions

- **OTHER:** Becaplermin nonusers
- **DRUG:** Becaplermin users

## Key facts

- **NCT ID:** NCT01235260
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** — (—)
- **Last updated:** 2016-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235260, "Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01235260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*